Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hu, PA
Baihua Hu, Audubon, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080319046 | SUBSTITUTED SULFONAMIDE-INDOLES - The present invention relates generally to substituted sulfonamide indoles such as substituted sulfonamide indoles, and methods of using them. | 12-25-2008 |
| 20090069373 | Quinoline Acids - This invention relates generally to quinoline-based modulators of Liver X receptors (LXRs) and related methods. | 03-12-2009 |
| 20100035957 | Methods for the Use of Inhibitors of Cytosolic Phospholipase A2 - This invention provides methods for the use of substituted indole compounds of the general formula: | 02-11-2010 |
| 20100120778 | QUINOXALINE-BASED LXR MODULATORS - Disclosed are quinoxaline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): | 05-13-2010 |
| 20100137363 | Substituted Indoles And Methods Of Their Use - The present invention relates generally to substituted indoles and methods of using them. | 06-03-2010 |
| 20100184786 | Polar Quinazolines - Disclosed are polar quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): | 07-22-2010 |
Binghua Hu, Audubon, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080248062 | Papillomavirus vaccine compositions - The present invention relates to pharmaceutical compositions comprising virus-like particles (VLPs) of HPV, said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid. In preferred embodiments, the aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate. Another aspect of the invention provides multi-dose HPV vaccine formulations comprising HPV VLPs and an antimicrobial preservative selected from the group consisting of: m-cresol, phenol and benzyl alcohol. Also provided are methods of using the disclosed pharmaceutical compositions and formulations to induce an immune response against HPV in a human patient and to prevent HPV infection. | 10-09-2008 |
Bo Hu, Greensburg, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110262294 | MACHINABILITY IMPROVING COMPOSITION - An iron-based powder composition is provided comprising, in addition to an iron-based powder, a minor amount of a machinability improving additive comprising at least one silicate from the group of phyllosilicates. The technology further concerns the use of the machinability improving additive and a method for producing an iron-based sintered part having improved machinability. | 10-27-2011 |
Fen Z. Hu, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110144318 | Selected nucleotide sequences isolated from pathogenic strains of haemophilus influenzae - A DNA sequence of | 06-16-2011 |
Guanghu Hu, Phoenixville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080267973 | Diagnosis and Treatment of Siglec-6 Associated Diseases - The present invention relates to agonists, antagonists, and other molecules that specifically bind SIGLEC-6 on mast cells, their use in the treatment of asthma and other SIGLEC-6 mediated diseases or disorders, methods of diagnosing such diseases or disorders, and methods of screening for candidate compounds capable of modulating SIGLEC-6 activity in mast cells. The present invention also relates to the diagnosis and treatment of B-cell related disorders using compounds that bind and/or modulate SIGLEC-6. | 10-30-2008 |
Guanghui Hu, Phoenixville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080292629 | System Clock Generation Circuit - A system clock signal generator circuit comprising a first PLL circuit that is frequency and phase locked to a wobble signal; a frequency and phase comparator for comprising a first output signal from the first PLL circuit with a system clock signal as frequency divided by M and for outputting a second output signal based on the differences in frequency and in phase; a PLL filter for providing a predetermined cutoff to the second output signal to output a third output signal; a pulse width modulating circuit for generating a pulse wave, the carrier frequency of which is a second reference clock signal, and for outputting a fourth output signal obtained by modulating the pulse width of the pulse wave by the third output signal; a low pass filter for smoothing the fourth output signal to output a fifth output signal; a VCO circuit the control voltage of which is the fifth output signal; a first frequency divider circuit for frequency dividing an output signal of the VCO circuit by N to output a system clock signal; and a second frequency divider circuit for frequency dividing, by M, and feeding the system clock signal back to the frequency and phase comparator. | 11-27-2008 |
| 20090156467 | Thymic stromal lymphpoietin promoter and use therefor - A promoter comprising the isolated promoter region of the human Thymic Stromal Lymphopoietin (TSLP) gene and functional portions of the promoter region having TSLP promoter activity. The promoters are useful for identifying promoter agonists and antagonists that can be used to prevent or treat allergic conditions and autoimmune diseases. | 06-18-2009 |
| 20100273661 | Methods and Kits for Predicting Treatment Response in Type II Diabetes Mellitus Patients - A method for predicting treatment response of a type II diabetes patient to rosiglitazone is provided. The method involves at least one sample from a patient having type II diabetes and analyzing biomarkers predictive of a patient who will respond to treatment with rosiglitazone. The biomarkers include, at least, interleukin-8, histidine, citrate. These biomarkers are identified in at least one classification analyses selected from the group consisting of a majority-vote based classifier and support-vector machine (SVM) classifier. Also provided is a method for predicting treatment response of a type II diabetes patient to glyburide at 8 weeks post-initiation of therapy. The method involves obtaining a sample from a type II diabetes patient who has been treated with glyburide for about 4 weeks and analyzing biomarkers predictive of a patient who will respond to treatment with glyburide at 8 weeks. The biomarkers useful in this method include, at least, sphingomyelin 23:1 and L-phenylalanine. Also provided are kits useful for the methods of the invention. | 10-28-2010 |
Jing Hu, State College, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120108562 | THERAPEUTIC COMPOSITIONS AND METHODS - PAD4 inhibitory compositions and methods for their use in treatment of cancer and autoimmune disease are provided according to embodiments of the present invention. | 05-03-2012 |
Libby Xiaowei Hu, Exton, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100152377 | PROCESS FOR PREPARING POLYESTER COMPOSITE MATERIALS - A process is provided for preparing polyester composite materials, comprising polymerizing at least one polyester precursor in the presence of filler microparticles and/or nanoparticles and organosilane having nucleophilic functionality. The organosilane is added as a distinct ingredient. The polyester composites so prepared have low acid end group content, thus improved hydrolytic and melt stability and improved elongation at break. | 06-17-2010 |
Min-Hsiung Hu, Murrysville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090092216 | STEAM GENERATOR DUAL SYSTEM SLUDGE AND LOOSE PARTS COLLECTOR - A U-tube steam generator having a dual system for collecting loose parts and sludge. A loose parts collector having a water overflow edge is disposed between a feedwater inlet and a tube bundle of the steam generator. A sludge collector having a water outlet is disposed downstream of the overflow edge of the loose parts collector and maintains a pressure differential between a water inlet of the sludge collector and the water outlet. | 04-09-2009 |
Ning Hu, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110213772 | Blending Mobile Search Results - Methods, systems, and apparatus, including computer program products, for blending mobile search results. A method includes receiving a search query and multiple search results. The search results each satisfy the search query and have a respective search result quality score. The search results include generic and mobile search results. The generic and mobile search results each identify a generic and mobile resource, respectively. The search result quality scores include mobile and generic search result quality scores for the mobile and generic search results, respectively. The mobile search result quality scores and the generic search result quality scores were generated according to different scoring formulas. Based on one or more terms in the search query, the search query is classified as a mobile query. As a consequence, one or more search result quality scores are modified to improve the sorting of search results that include both mobile and generic search results. | 09-01-2011 |
Rong M. Hu, Norristown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080261019 | Pvc/Wood Composite - The present invention relates to a thermoplastic/natural cellulosic fiber composite, and more specifically to a high molecular weight compatibilizer within that composite resulting in both a high flex strength and high modulus and significant reduction in water absorption. The compatibilizer is preferably a terpolymer comprising: a) 0.5-20 percent by weight of monomer units selected from the group consisting of maleic anhydride, substituted maleic anhydride, mono-ester of maleic anhydride, itaconic anhydride, maleic acid, fumaric acid, crotonic acid, acrylic acid and methacrylic acid; b) 0 to 40 percent by weight of monomer units selected from styrene and functionalized styrene; and c) 40 to 98.5 percent by weight of monomer units selected from the group consisting of C | 10-23-2008 |
| 20090111915 | ACRYLIC COPOLYMER FOR USE IN HIGHLY FILLED COMPOSITES - The invention relates to an acrylic copolymer additive useful as a process aid in highly filled polyvinyl chloride (PVC) and chlorinated polyvinyl chloride (CPVC) composites. The acrylic additive is especially useful in highly filled PVC flooring tiles, rolled flooring, pipe and siding. The acrylic copolymer additive contains from 50 to 79 weight percent of methyl methacrylate monomer units, and has a Tg of less than 90° C. | 04-30-2009 |
Rong Maria Hu, Norristown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110315189 | ACRYLIC PHOTOVOLTAIC MODULE BACKSHEET - The invention relates to an acrylic layer (in the form of a coating, film or sheet) useful as part of a photovoltaic module backsheet. The acrylic layer contains at least 40 percent of one or more acrylic polymers, including an acrylic polymer matrix and optionally acrylic impact modifiers. The acrylic polymer is preferably a polymer, copolymer, or terpolymer containing at least 50 weight percent of methylmethacrylate monomer units. The acrylic layer is flexible and optionally contains high levels of white pigment. It may also contain fluoropolymers such as polyvinylidene fluoride to improve weathering, processibility and film formation. The acrylic layer adheres to a polymer support layer such as polyethylene terephthalate (PET). A preferred substrate is PET that is pre-treated to improve adhesion, but unprimed PET can also be used. The backsheet provides excellent weatherability, environmental stability and reflectivity as part of a photovoltaic module. | 12-29-2011 |
Shan Hu, Allison Park, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100187583 | Reconfigurable Electric Circuitry and Method of Making Same - A reconfigurable electric circuit includes first and second crystalline material layers positioned adjacent to each other and forming a first interface, and a first ferroelectric layer positioned adjacent to the first crystalline material layer and having ferroelectric domains applying an electric field to regions of the first interface to induce a quasi two-dimensional electron gas in the regions, wherein at least one of the regions forms a gate and at least one of the regions forms a channel. | 07-29-2010 |
Shan Hu, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100110754 | NON-DESTRUCTIVE READ BACK FOR FERROELECTRIC DATA STORAGE DEVICE - A data storage device comprising a ferroelectric layer, a perovskite structure, and at least one sensor, where the perovskite structure has a polarity discontinuity configured to generate capacitance voltages in the perovskite structure based on polarization charges of the ferroelectric material, and where the at least one sensor is configured to read the capacitance voltages from the perovskite structure. | 05-06-2010 |
Yong Hu, King Of Prussia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090285887 | Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor - A modified release pharmaceutical composition for oral administration comprising plural mini-tablets, comprising a therapeutically effective amount of a Factor Xa inhibitor within a matrix of polymer(s). The mini-tablets are suitably encapsulated within a gelatin capsule. A manufacturing process and method of use are also described. | 11-19-2009 |
Youji Hu, Gulph Mills, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100221753 | Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Macroarray Proteomics Platforms - The invention relates to novel nucleic acids encoding a mammalian PCADM-1 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, prostate cancer. The invention further relates to methods of detecting and treating prostate cancer, comprising modulating or detecting PCADM-1 expression and/or production and activity of PCADM-1 polypeptide. Further, the invention relates to novel assays for the identification of DNA-binding proteins and the double-stranded oligonucleotide sequences that specifically bind with them. Finally, the invention relates to DNAZYMs or DNA enzymes which specifically bind PCADM-1 mRNA to inhibit PCADM-1 gene expression and thereby destroy tumor cells and tumor tissue. | 09-02-2010 |
| 20110111979 | Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Microarray Proteomics Platforms - The invention relates to novel nucleic acids encoding a mammalian PCADM-1 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, prostate cancer, The invention further relates to methods of detecting and treating prostate cancer, comprising modulating or detecting PCADM-1 expression and/or production and activity of PCADM-1 polypeptide. Further, the invention relates to novel assays for the identification of DNA-binding proteins and the double-stranded oligonucleotide sequences that specifically bind with them. Finally, the invention relates to DNAZYMs or DNA enzymes which specifically bind PCADM-1 mRNA to inhibit PCADM-1 gene expression and thereby destroy tumor cells and tumor tissue. | 05-12-2011 |
Youji Hu, Ghulph Mills, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100184843 | IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER - The invention relates to nucleic acids encoding a mammalian ABCA5 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, PIN. Further, the invention relates to diagnostic assays for identifying the DNA-binding protein ABCA5 (also known as PIN-1). The invention also relates to oligonucleotide sequence(s) or antibodies that specifically bind with ABCA5 or variants thereof. | 07-22-2010 |
Yufeng Hu, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090052222 | MEMORY ELEMENT WITH THERMOELECTRIC PULSE - A memory element comprises an addressable memory cell. A thermoelectric device couples to the memory cell. Electrical conductors provide a current pulse to the thermoelectric device. The current pulse generates a thermoelectric heat flow pulse between the thermoelectric device and the memory cell. | 02-26-2009 |
Zilun Hu, Jamison, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100022506 | ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS - The present invention provides compounds of Formula (I): | 01-28-2010 |
| 20110021492 | PYRIDAZINE DERIVATIVES AS FACTOR XIA INHIBITORS - The present invention provides compounds of Formula (I): | 01-27-2011 |
| 20110028446 | ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS - The present invention provides compounds of Formula (I): | 02-03-2011 |
| 20120041190 | MACROCYCLES AS FACTOR XIA INHIBITORS - The present invention provides compounds of Formula (I): | 02-16-2012 |